CTRI/2018/05/014237CompletedPhase 3
A randomized controlled single blind clinical trial to evaluate efficacy of empirical treatment with Albendazole in delaying disease progression amongst HIV positive ART naïve patients at an ART centre of a tertiary care hospital
AFMC0 sites160 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 160
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •HIV positive adults more than 18yrs of age
- •HIV positive patients not on ART
- •HIV positive patients not meeting WHO clinical criteria for initiation of ART
- •CD4 count >500/mm3 at baseline
Exclusion Criteria
- •Patients who have opportunistic infection
Investigators
Similar Trials
Completed
Phase 2
Clinical trial for safety and efficacy of grassroots leads in the management of Osteoarthritis of knee joints.CTRI/2019/06/019881ational innovation foundation300
Not yet recruiting
Phase 2
Treatment for underweight subjects using one ayurvedic formulation and soy protein powderCTRI/2023/07/054599Dr Anita M Bellad
Terminated
Not Applicable
A clinical trial measuring a new clinical psychology intervention on improving outcomes for people with schizophrenia and distressing voice hallucinations.schizophreniaACTRN12616001499471orth Metropolitan Health Service -Adult Mental Health45
Terminated
Phase 2
A clinical trial about the effectiveness of a supported employment linkage intervention for people with schizophrenia admitted to an adult mental health unit who want to work.Mental Health - SchizophreniaSchizophreniaACTRN12616001638426orth Metropolitan Health Service -Adult Mental Health49
Completed
Not Applicable
Clinical trial of Ossguide® for ridge preservation procedureDiseases of the digestive systemKCT0001708Bioland30